VIRIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO SOLUBLE CD4 (SCD4) NEUTRALIZATION DIFFER IN SCD4 BINDING AND GLYCOPROTEIN GP120 RETENTION FROM SCD4-SENSITIVE ISOLATES

被引:297
作者
MOORE, JP
MCKEATING, JA
HUANG, YX
ASHKENAZI, A
HO, DD
机构
[1] INST CANC RES, CHESTER BEATTY LABS, LONDON SW3 6JB, ENGLAND
[2] GENENTECH INC, DEPT IMMUNOBIOL, SAN FRANCISCO, CA 94080 USA
关键词
D O I
10.1128/JVI.66.1.235-243.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Primary isolates of human immunodeficiency virus type 1 (HIV-1) are much less sensitive to neutralization by soluble CD4 (sCD4) and sCD4-immunoglobulin (Ig) chimeras (CD4-IgG) than are HIV-1 strains adapted to growth in cell culture. We demonstrated that there are significant reductions (10- to 30-fold) in the binding of sCD4 and CD4-IgG to intact virions of five primary isolates compared with sCD4-sensitive, cell culture-adapted isolates RF and IIIB. However, soluble envelope glycoproteins (gp120) derived from the primary isolate virions, directly by detergent solubilization or indirectly by recombinant DNA technology, differed in affinity from RF and IIIB gp120 by only one- to threefold. The reduced binding of sCD4 to these primary isolate virions must therefore be a consequence of the tertiary or quaternary structure of the envelope glycoproteins in their native, oligomeric form on the viral surface. In addition, the rate and extent of sCD4-induced gp120 shedding from these primary isolates was lower than that from RF. We suggest that reduced sCD4 binding and increased gp120 retention together account for the relative resistance of these primary isolates to neutralization by sCD4 and CD4-IgG and that virions of different HIV-1 isolates vary both in the mechanism of sCD4 binding and in subsequent conformational changes in their envelope glycoproteins.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 64 条
[1]   ENHANCEMENT OF SIV INFECTION WITH SOLUBLE RECEPTOR MOLECULES [J].
ALLAN, JS ;
STRAUSS, J ;
BUCK, DW .
SCIENCE, 1990, 247 (4946) :1084-1088
[2]  
ALLAN JS, 1991, SCIENCE, V252, P1322, DOI 10.1126/science.1925547
[3]  
ARNOLD E, 1991, ADV VIRUS RES, V39, P1
[4]   MAPPING THE CD4 BINDING-SITE FOR HUMAN-IMMUNODEFICIENCY-VIRUS BY ALANINE-SCANNING MUTAGENESIS [J].
ASHKENAZI, A ;
PRESTA, LG ;
MARSTERS, SA ;
CAMERATO, TR ;
ROSENTHAL, KA ;
FENDLY, BM ;
CAPON, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7150-7154
[5]   RESISTANCE OF PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO SOLUBLE CD4 IS INDEPENDENT OF CD4-RGP120 BINDING-AFFINITY [J].
ASHKENAZI, A ;
SMITH, DH ;
MARSTERS, SA ;
RIDDLE, L ;
GREGORY, TJ ;
HO, DD ;
CAPON, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7056-7060
[6]   BIOLOGICAL PROPERTIES OF A CD4 IMMUNOADHESIN [J].
BYRN, RA ;
MORDENTI, J ;
LUCAS, C ;
SMITH, D ;
MARSTERS, SA ;
JOHNSON, JS ;
COSSUM, P ;
CHAMOW, SM ;
WURM, FM ;
GREGORY, T ;
GROOPMAN, JE ;
CAPON, DJ .
NATURE, 1990, 344 (6267) :667-670
[7]   CHARACTERIZATION OF INVITRO INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS BY PURIFIED RECOMBINANT CD4 [J].
BYRN, RA ;
SEKIGAWA, I ;
CHAMOW, SM ;
JOHNSON, JS ;
GREGORY, TJ ;
CAPON, DJ ;
GROOPMAN, JE .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4370-4375
[8]   DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY [J].
CAPON, DJ ;
CHAMOW, SM ;
MORDENTI, J ;
MARSTERS, SA ;
GREGORY, T ;
MITSUYA, H ;
BYRN, RA ;
LUCAS, C ;
WURM, FM ;
GROOPMAN, JE ;
BRODER, S ;
SMITH, DH .
NATURE, 1989, 337 (6207) :525-531
[9]  
CHIRMULE N, 1988, J ACQ IMMUN DEF SYND, V1, P425
[10]   SOLUBLE CD4 BLOCKS THE INFECTIVITY OF DIVERSE STRAINS OF HIV AND SIV FOR T-CELLS AND MONOCYTES BUT NOT FOR BRAIN AND MUSCLE-CELLS [J].
CLAPHAM, PR ;
WEBER, JN ;
WHITBY, D ;
MCINTOSH, K ;
DALGLEISH, AG ;
MADDON, PJ ;
DEEN, KC ;
SWEET, RW ;
WEISS, RA .
NATURE, 1989, 337 (6205) :368-370